ArticleInterdisciplinary sciences, computational life sciences2025
A Molecular Fragment Representation Learning Framework for Drug-Drug Interaction Prediction.
Article in Interdisciplinary sciences, computational life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Computational approaches for drug-drug interaction prediction: a systematic review of data sources, modeling strategies, and evaluation frameworks.Frontiers in pharmacology · 2026Pooled it
- Unveiling the molecular mechanisms of stigmasterol on diabetic retinopathy: BNM framework construction and experimental validation.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The concurrent use of multiple drugs may result in drug-drug interactions, increasing the risk of adverse reactions. Hence, it is particularly crucial to propose computational methods for precisely identifying unknown drug-drug interactions, which is of great significance for drug development and health. However, most recent studies have limited the drug-drug interaction prediction task to identifying interactions between substructures, overlooking molecular hierarchical information. Moreover, the extracted substructures in these methods are always restricted to have the same number of atoms as contained in the molecular graph, which does not align with real-world facts. In this study, a molecular fragment representation learning framework for drug-drug interaction prediction is introduced. Initially, a fragment extraction module is designed to acquire a series of molecular fragments. Subsequently, to capture more comprehensive features, molecular hierarchical information is effectively integrated, enabling drug-drug interaction prediction by identifying pairwise interactions between molecular fragments of each drug. Comprehensive evaluations demonstrate that the proposed method achieved state-of-the-art performance in both DrugBank and Twosides datasets, particularly achieving an improved accuracy of over 20% for unseen drugs in both two datasets. Furthermore, case studies and visual analysis confirm that the proposed method can accurately identify crucial substructures influencing the interactions, which are basically consistent with functional group structures in reality. In conclusion, this method not only enhances the performance of drug-drug interaction prediction but also offers high interpretability. Source code is freely available at https://github.com/kennysyp/MFR-DDI .
Indexed as
Identifiers
39382821What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.